JP2010532157A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532157A5
JP2010532157A5 JP2010502098A JP2010502098A JP2010532157A5 JP 2010532157 A5 JP2010532157 A5 JP 2010532157A5 JP 2010502098 A JP2010502098 A JP 2010502098A JP 2010502098 A JP2010502098 A JP 2010502098A JP 2010532157 A5 JP2010532157 A5 JP 2010532157A5
Authority
JP
Japan
Prior art keywords
recombinant
turkey herpesvirus
influenza virus
avian
herpesvirus according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532157A (ja
JP5508252B2 (ja
Filing date
Publication date
Priority claimed from US11/729,978 external-priority patent/US20080241188A1/en
Application filed filed Critical
Publication of JP2010532157A publication Critical patent/JP2010532157A/ja
Publication of JP2010532157A5 publication Critical patent/JP2010532157A5/ja
Application granted granted Critical
Publication of JP5508252B2 publication Critical patent/JP5508252B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502098A 2007-03-30 2008-03-28 鳥インフルエンザ遺伝子を含有する組み換え七面鳥ヘルペスウイルス Active JP5508252B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/729,978 2007-03-30
US11/729,978 US20080241188A1 (en) 2007-03-30 2007-03-30 Turkey herpesvirus vectored recombinant containing avian influenza genes
PCT/US2008/004070 WO2008121329A2 (en) 2007-03-30 2008-03-28 Turkey herpesvirus vectored recombinant containing avian influenza genes

Publications (3)

Publication Number Publication Date
JP2010532157A JP2010532157A (ja) 2010-10-07
JP2010532157A5 true JP2010532157A5 (cg-RX-API-DMAC7.html) 2011-05-19
JP5508252B2 JP5508252B2 (ja) 2014-05-28

Family

ID=39794757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502098A Active JP5508252B2 (ja) 2007-03-30 2008-03-28 鳥インフルエンザ遺伝子を含有する組み換え七面鳥ヘルペスウイルス

Country Status (7)

Country Link
US (4) US20080241188A1 (cg-RX-API-DMAC7.html)
EP (1) EP2129390B1 (cg-RX-API-DMAC7.html)
JP (1) JP5508252B2 (cg-RX-API-DMAC7.html)
CN (1) CN101903040A (cg-RX-API-DMAC7.html)
ES (1) ES2399845T3 (cg-RX-API-DMAC7.html)
PL (1) PL2129390T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008121329A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
CA2689181A1 (en) 2007-05-30 2008-12-24 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
MX2010013693A (es) * 2008-06-23 2010-12-21 Intervet Int Bv Virus de herpes recombinante de pavos que codifica para interleucina-12.
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
EP2419132B1 (en) * 2009-04-15 2014-06-25 Ceva Sante Animale Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
AU2009344843A1 (en) * 2009-04-23 2011-11-10 Elenore S. Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
CN103370079B (zh) * 2010-10-18 2016-08-10 英特维特国际股份有限公司 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN103740759B (zh) * 2014-01-20 2016-04-06 中国农业科学院哈尔滨兽医研究所 表达h5n1亚型禽流感病毒ha基因的重组火鸡疱疹病毒
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
PL3471766T3 (pl) 2016-06-17 2023-04-11 Intervet International B.V. Rekombinowane konstrukty niepatogennego wirusa choroby Mareka kodujące antygeny wirusa zakaźnego zapalenia krtani i tchawicy oraz wirusa zakaźnego zapalenia torby Fabrycjusza
CN106497893A (zh) * 2016-10-28 2017-03-15 扬州大学 表达H7N9亚型禽流感病毒嵌合型血凝素蛋白的重组火鸡疱疹病毒株rHMW及构建方法
CN106399267A (zh) * 2016-10-28 2017-02-15 扬州大学 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法
MX2020003591A (es) 2017-10-12 2020-07-22 Intervet Int Bv Constructos del virus recombinante no patogenico de la enfermedad de marek que codifica multiples antigenos heterologos.
CN109142734B (zh) * 2018-10-26 2021-07-16 北京纳百生物科技有限公司 禽流感病毒H5亚型Re-6株抗体鉴定试剂盒
CN109402071B (zh) * 2018-11-08 2021-04-27 中国农业大学 一种表达h9n2亚型禽流感病毒h9蛋白的重组火鸡疱疹病毒
CN110205308A (zh) * 2019-05-24 2019-09-06 华南农业大学 一种表达ha基因的重组火鸡疱疹病毒及其应用
CN114828882A (zh) * 2019-12-20 2022-07-29 英特维特国际股份有限公司 多价hvt载体疫苗
MX2023004358A (es) 2020-10-15 2023-07-25 Ceva Sante Animale Hvt recombinante y usos de este.
CN114184797B (zh) * 2021-12-06 2024-06-14 辽宁成大生物股份有限公司 一种流感病毒裂解疫苗单价原液血凝素的检测方法
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip
CN120555370A (zh) * 2024-02-29 2025-08-29 诗华动保科技(杭州)有限公司 重组hvt及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5916879A (en) * 1996-11-12 1999-06-29 St. Jude Children's Research Hospital DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof
EP1026246B1 (en) * 1997-10-03 2006-11-29 Zeon Corporation Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6866852B2 (en) * 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
NZ543348A (en) * 2003-05-05 2008-08-29 Thompson Boyce Plant Res Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
JP2009512421A (ja) * 2005-08-15 2009-03-26 ヴァクシン インコーポレイテッド 非複製性ベクターワクチン投与による鳥類への免疫方法

Similar Documents

Publication Publication Date Title
JP2010532157A5 (cg-RX-API-DMAC7.html)
Chen et al. Advances in development and application of influenza vaccines
Gu et al. Current situation of H9N2 subtype avian influenza in China
Li et al. Avian influenza vaccines against H5N1 ‘bird flu’
Lee et al. H9N2 avian influenza virus in Korea: evolution and vaccination
Kistner et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
RU2018116857A (ru) Мультивалентные рекомбинантные вирусы птичьего герпеса и вакцины для иммунизации птиц
Bardiya et al. Influenza vaccines: recent advances in production technologies
JP2016155867A5 (cg-RX-API-DMAC7.html)
Xu et al. Phylogenetic classification of hemagglutinin gene of H9N2 avian influenza viruses isolated in China during 2012–2016 and evaluation of selected candidate vaccine strains
JP2015500806A5 (cg-RX-API-DMAC7.html)
JP2015119730A5 (cg-RX-API-DMAC7.html)
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
US20120269849A1 (en) Attenuated influenza viruses and vaccines
CA2604330A1 (en) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
CN101636177A (zh) 用于禽流感的基于重组改良型痘苗病毒安卡拉(mva)的疫苗
Jang et al. Principles underlying rational design of live attenuated influenza vaccines
WO2010134094A1 (en) Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
JP2016501020A5 (cg-RX-API-DMAC7.html)
Umar et al. Emerging threat of H9N2 viruses in poultry of Pakistan and vaccination strategy
Kim et al. Recent outbreaks of highly pathogenic avian influenza viruses in South Korea
Deng et al. Developments of subunit and VLP vaccines against influenza A virus
Steel New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges
Zhou et al. High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1
Rockman et al. Pre-pandemic and pandemic influenza vaccines